Burling Wealth Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.81M Sell
26,200
-44
-0.2% -$6.08K 0.54% 43
2026
Q2
$3.37M Sell
26,244
-719
-3% -$84.2K 0.49% 52
2026
Q1
$3.24M Sell
26,963
-1,950
-7% -$225K 0.52% 52
2025
Q4
$3.04M Sell
28,913
-1,573
-5% -$148K 0.47% 54
2025
Q3
$2.56M Sell
30,486
-9,333
-23% -$769K 0.42% 64
2025
Q2
$3.15M Sell
39,819
-6,233
-14% -$495K 0.58% 52
2025
Q1
$4.13M Sell
46,052
-10,328
-18% -$964K 0.87% 34
2024
Q4
$5.61M Buy
+56,380
New +$5.81M 1.14% 26

Other funds holding MRK

Burling Wealth Partners's MRK Position: Q3 2026 in Review

Burling Wealth Partners reduced its Merck (MRK) stake by 0.17% in Q3 2026, selling an estimated $6.08K and leaving 26,200 shares worth $3.81M. The position accounts for 0.54% of the portfolio, ranked #43.

Burling Wealth Partners first reported a position in MRK in Q4 2024 and has held it in 8 quarters since. The position peaked at $5.61M in Q4 2024. 3,974 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Burling Wealth Partners held 26,200 shares of Merck worth $3.81M as of Q3 2026.
  • Burling Wealth Partners sold 44 Merck shares in Q3 2026, an estimated $6.08K.
  • Merck made up 0.54% of Burling Wealth Partners's portfolio in Q3 2026, its #43 holding.
  • Burling Wealth Partners first reported a position in Merck in Q4 2024 and has held it in 8 quarters since.
  • Burling Wealth Partners's Merck position peaked at $5.61M in Q4 2024.
  • 3,974 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Burling Wealth Partners's 13F filing for Q3 2026, filed 9 Nov 2026.